BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37835427)

  • 1. Reproducible Bioinformatics Analysis Workflows for Detecting
    Thomson AJ; Rehn JA; Heatley SL; Eadie LN; Page EC; Schutz C; McClure BJ; Sutton R; Dalla-Pozza L; Moore AS; Greenwood M; Kotecha RS; Fong CY; Yong ASM; Yeung DT; Breen J; White DL
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion InPipe, an integrative pipeline for gene fusion detection from RNA-seq data in acute pediatric leukemia.
    Vicente-Garcés C; Maynou J; Fernández G; Esperanza-Cebollada E; Torrebadell M; Català A; Rives S; Camós M; Vega-García N
    Front Mol Biosci; 2023; 10():1141310. PubMed ID: 37363396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach for direct detection of the IGH::CRLF2 gene fusion by fluorescent in situ hybridization.
    González-Arreola RM; García-Romero A; Magaña-Torres MT; González-García JR
    Mol Cytogenet; 2023 Aug; 16(1):19. PubMed ID: 37574565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Philadelphia chromosome-negative B-cell acute lymphoblastic leukaemia with kinase fusions in Taiwan.
    Hsu YC; Yu CH; Chen YM; Roberts KG; Ni YL; Lin KH; Jou ST; Lu MY; Chen SH; Wu KH; Chang HH; Lin DT; Lin SW; Lin ZS; Chiu WT; Chang CC; Ho BC; Mullighan CG; Yu SL; Yang YL
    Sci Rep; 2021 Mar; 11(1):5802. PubMed ID: 33707599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of clinically relevant fusions in pediatric cancer.
    LaHaye S; Fitch JR; Voytovich KJ; Herman AC; Kelly BJ; Lammi GE; Arbesfeld JA; Wijeratne S; Franklin SJ; Schieffer KM; Bir N; McGrath SD; Miller AR; Wetzel A; Miller KE; Bedrosian TA; Leraas K; Varga EA; Lee K; Gupta A; Setty B; Boué DR; Leonard JR; Finlay JL; Abdelbaki MS; Osorio DS; Koo SC; Koboldt DC; Wagner AH; Eisfeld AK; Mrózek K; Magrini V; Cottrell CE; Mardis ER; Wilson RK; White P
    BMC Genomics; 2021 Dec; 22(1):872. PubMed ID: 34863095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor 12-mediated self-feedback regulatory mechanism is required in DUX4 fusion leukaemia.
    Li Z; Jiang M; Wang J; Zhuo Z; Zhang S; Tan Y; Hu W; Zhang H; Meng G
    Clin Transl Med; 2023 Dec; 13(12):e1514. PubMed ID: 38115701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. annoFuse: an R Package to annotate, prioritize, and interactively explore putative oncogenic RNA fusions.
    Gaonkar KS; Marini F; Rathi KS; Jain P; Zhu Y; Chimicles NA; Brown MA; Naqvi AS; Zhang B; Storm PB; Maris JM; Raman P; Resnick AC; Strauch K; Taroni JN; Rokita JL
    BMC Bioinformatics; 2020 Dec; 21(1):577. PubMed ID: 33317447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Exome Capture-Based RNA-Sequencing Assay for Genome-Wide Identification and Prioritization of Clinically Important Fusions in Pediatric Tumors.
    Buckley J; Schmidt RJ; Ostrow D; Maglinte D; Bootwalla M; Ruble D; Govindarajan A; Ji J; Kovach AE; Orgel E; Raca G; Navid F; Mascarenhas L; Pawel B; Robison N; Gai X; Biegel JA
    J Mol Diagn; 2024 Feb; 26(2):127-139. PubMed ID: 38008288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemia.
    Moorman AV; Schwab C; Ensor HM; Russell LJ; Morrison H; Jones L; Masic D; Patel B; Rowe JM; Tallman M; Goldstone AH; Fielding AK; Harrison CJ
    J Clin Oncol; 2012 Sep; 30(25):3100-8. PubMed ID: 22851563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
    Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S
    Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?
    Dyer MJ; Akasaka T; Capasso M; Dusanjh P; Lee YF; Karran EL; Nagel I; Vater I; Cario G; Siebert R
    Blood; 2010 Feb; 115(8):1490-9. PubMed ID: 20042721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification and genetics of pediatric B-other acute lymphoblastic leukemia by targeted RNA sequencing.
    Migita NA; Jotta PY; Nascimento NPD; Vasconcelos VS; Centoducatte GL; Massirer KB; Azevedo AC; Brandalise SR; Yunes JA
    Blood Adv; 2023 Jul; 7(13):2957-2971. PubMed ID: 36848637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-risk cytogenetics in multiple myeloma: Further scrutiny of deletions within the IGH gene region enhances risk stratification.
    Smith SC; Althof PA; Dave BJ; Sanmann JN
    Genes Chromosomes Cancer; 2020 Oct; 59(10):569-574. PubMed ID: 32447782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA crosslinking and recombination-activating genes 1/2 (RAG1/2) are required for oncogenic splicing in acute lymphoblastic leukemia.
    Zhang H; Cheng N; Li Z; Bai L; Fang C; Li Y; Zhang W; Dong X; Jiang M; Liang Y; Zhang S; Mi J; Zhu J; Zhang Y; Chen SJ; Zhao Y; Weng XQ; Hu W; Chen Z; Huang J; Meng G
    Cancer Commun (Lond); 2021 Nov; 41(11):1116-1136. PubMed ID: 34699692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of High-risk Cryptic CRLF2 Rearrangements in B-Cell Acute Lymphoblastic Leukemia Utilizing an FGFR3/IGH Dual-Color Dual-Fusion DNA Probe Set.
    Robin AJ; Peterson JF; Grignon JW; Gheorghe G; Burke MJ; vanTuinen P
    J Pediatr Hematol Oncol; 2017 May; 39(4):e207-e210. PubMed ID: 27820126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
    Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY
    Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Submicroscopic deletions of immunoglobulin heavy chain gene (IGH) in precursor B lymphoblastic leukemia with IGH rearrangements.
    Huh J; Mun YC; Yoo ES; Seong CM; Chung WS
    Ann Lab Med; 2015 Jan; 35(1):128-31. PubMed ID: 25553293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood.
    Schmäh J; Fedders B; Panzer-Grümayer R; Fischer S; Zimmermann M; Dagdan E; Bens S; Schewe D; Moericke A; Alten J; Bleckmann K; Siebert R; Schrappe M; Stanulla M; Cario G
    Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28371317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel kinase fusion transcripts in paediatric B cell precursor acute lymphoblastic leukaemia with IKZF1 deletion.
    Yano M; Imamura T; Asai D; Kiyokawa N; Nakabayashi K; Matsumoto K; Deguchi T; Hashii Y; Honda YK; Hasegawa D; Sasahara Y; Ishii M; Kosaka Y; Kato K; Shima M; Hori H; Yumura-Yagi K; Hara J; Oda M; Horibe K; Ichikawa H; Sato A
    Br J Haematol; 2015 Dec; 171(5):813-7. PubMed ID: 26404892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RaScALL: Rapid (Ra) screening (Sc) of RNA-seq data for prognostically significant genomic alterations in acute lymphoblastic leukaemia (ALL).
    Rehn J; Mayoh C; Heatley SL; McClure BJ; Eadie LN; Schutz C; Yeung DT; Cowley MJ; Breen J; White DL
    PLoS Genet; 2022 Oct; 18(10):e1010300. PubMed ID: 36251721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.